Cargando…

It Is the Time to Think About a Treat-to-Target Strategy for Knee Osteoarthritis

Osteoarthritis (OA) is a rheumatic disease that affects the well-being of the patient, compromises physical and mental function, and affects other quality of life aspects. In the literature, several evidence-based guidelines and recommendations for the management of knee osteoarthritis (KOA) are ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Migliore, A, Gigliucci, G, Petrella, RJ, Bannuru, RR, Chevalier, X, Maheu, E, Raman, R, Herrero-Beaumont, G, Isailovic, N, Matucci Cerinc, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935020/
https://www.ncbi.nlm.nih.gov/pubmed/31920321
http://dx.doi.org/10.2147/TCRM.S221562
Descripción
Sumario:Osteoarthritis (OA) is a rheumatic disease that affects the well-being of the patient, compromises physical and mental function, and affects other quality of life aspects. In the literature, several evidence-based guidelines and recommendations for the management of knee osteoarthritis (KOA) are available. These recommendations list the different therapeutic options rather than addressing a hierarchy between the treatments and defining the real target. Therefore, a question arises: are patients and physicians satisfied with the current management of KOA? Actually, the answer may be negative, thus suggesting a change in our therapeutic strategies. In this article, we address this challenge by suggesting that it is time to develop a “treat to target strategy” for KOA.